Aberjona Laboratories — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Aberjona Laboratories is a private, revenue-generating service and product provider focused on the drug discovery sector. Founded in 1990 and headquartered in Woburn, MA, the company specializes in rapid, high-quality organic synthesis and medicinal chemistry services, supporting clients from concept to candidate synthesis. Its credibility is bolstered by co-invented clinical-stage candidates, patents, and award-winning scientific publications. The company operates from a wholly-owned state-of-the-art facility near Boston, catering primarily to pharmaceutical and biotech partners.

Diagnostics

Technology Platform

Expertise in high-speed organic and medicinal chemistry synthesis, enabling rapid design and production of drug candidates with turnaround times from 2 days to 2 weeks.

Opportunities

The growing trend of pharmaceutical R&D outsourcing and its prime location in the Boston biotech hub provide a steady stream of potential clients.

Its proven track record of co-inventing clinical-stage candidates allows it to pursue high-value, strategic collaborations beyond simple fee-for-service work.

Risk Factors

Faces intense competition in the chemistry CRO market from both large global players and small boutiques.

Revenue is susceptible to fluctuations in client R&D budgets and the potential loss of key partnerships, highlighting client concentration and economic sensitivity risks.

Competitive Landscape

Aberjona competes in the fragmented drug discovery services market, contending with large, full-service CROs (e.g., Charles River, WuXi) and numerous specialized medicinal chemistry boutiques. Its differentiation is based on claimed superior speed, quality, and a proven ability to co-invent clinical candidates, rather than scale.

More companies in Small Molecule Drugs →More companies in United States →